-
search
-
follow updates:
advertisement:
our partners:
categories
- adipose (11)
- cancer (39)
- cell culture (35)
- cell product (65)
- cell separation (16)
- clinical lab (28)
- consensus (11)
- cord blood (19)
- cytometry (23)
- direct reprogramming (12)
- educational (27)
- embryonic/iPS (88)
- events (10)
- gadgets (11)
- gene transfer (6)
- hematopoietic (79)
- interviews (13)
- lectures (45)
- mesenchymal (46)
- methods (52)
- neural (15)
- notes (124)
- open science (31)
- other adult stem cells (15)
- protocols (64)
- RegenMed digest (41)
- reviews (47)
- tissue engineering (12)
- web tools (13)
series:
featured posts:
Proposal for ISCT to revise the definition and minimal criteria of mesenchymal stromal cells
CD34 expression on human mesenchymal stromal cells
Notable market approvals in 2012
Impact of fetal bovine serum on toxicity of mesenchymal stromal cell infusions in humans
FDA’s position on assessment of tumorigenic potential of cell products for regenerative medicine
polls:
recent comments
- Paul Knoepfler on Cells Weekly – June 9, 2013
- Andrew Laslett on Assay for identification of unsafe iPS cell lines
- Alexey Bersenev on Assay for identification of unsafe iPS cell lines
- Andrew Laslett on Assay for identification of unsafe iPS cell lines
- Natalie DeWitt on On reproducibility of scientific findings
blogs we recommend:
popular tags:
assay banking business cancer cancer stem cell CD34 cell culture cell processing cell product cell separation cells weekly cell therapy clinical-grade clinical trial collaboration conference cord blood direct transdifferentiation discussion embryonic stem cell expansion fda flow cytometry HSC iPS jove lecture marker market method MSC MSC assays MSC isolation open science pluripotency protocol protocols digest regenerative medicine RegenMed reprogramming review risk safety tissue engineering videocell therapy trials tracking:
databases:
license:
Get smart with the Thesis WordPress Theme from DIYthemes.